Evidence map›Paper›PMID 27194424›Full record

ReviewPediatric nephrology (Berlin, Germany)2017

Potassium: friend or foe?

Aylin R Rodan

Abstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Electrolyte Imbalance and Neurologic Injury.CNS & neurological disorders drug targets · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Extravasation of Concentrated Potassium Chloride: A Case Report.Current therapeutic research, clinical and experimental · 2021
    Article
  15. WNK4 kinase is a physiological intracellular chloride sensor.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Effect of Hypokalemia on Functional Outcome at 3 Months Post-Stroke Among First-Ever Acute Ischemic Stroke Patients.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Aylin R RodanDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390-8856, USA. Aylin.rodan@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

WNK & SPAK/OSR1 regulation of SLC12 cotransporters in DrosophilaK08DK091316 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI RODAN, AYLIN RACHEL · 2011 to 2015
$727k
Probing intracellular Cl- in a WNK signaling-dependent transporting epitheliumR03DK106350 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI RODAN, AYLIN RACHEL · 2015 to 2016
$156k
NIDDK NIH HHS K08 DK091316NIDDK NIH HHS R03 DK106350
6 · The paper itself

Abstract

The kidney plays an essential role in maintaining homeostasis of ion concentrations in the blood. Because the concentration gradient of potassium across the cell membrane is a key determinant of the membrane potential of cells, even small deviations in serum potassium level from the normal setpoint can lead to severe muscle dysfunction, resulting in respiratory failure and cardiac arrest. Less severe hypo- and hyperkalemia are also associated with morbidity and mortality across various patient populations. In addition, deficiencies in potassium intake have been associated with hypertension and adverse cardiovascular and renal outcomes, likely due in part to the interrelated handling of sodium and potassium by the kidney. Here, data on the beneficial effects of potassium on blood pressure and cardiovascular and renal outcomes will be reviewed, along with the physiological basis for these effects. In some patient populations, however, potassium excess is deleterious. Risk factors for the development of hyperkalemia will be reviewed, as well as the risks and benefits of existing and emerging therapies for hyperkalemia.

Indexed as

AldosteroneCation Exchange ResinsCell MembraneChildHeart FailureHomeostasisHumansHyperkalemiaHypertensionHypokalemiaKidneyMembrane PotentialsPolymersPotassiumPotassium, DietaryProtein Serine-Threonine KinasesAldosteroneCation Exchange ResinsOXSR1 protein, humanpatiromerPolymersPotassiumPotassium, DietaryProtein Serine-Threonine KinasesSilicatesSodiumSodium Chloride Symporterssodium zirconium cyclosilicateSTK39 protein, humanWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1HyperkalemiaHypokalemiaPatiromerPotassium homeostasisPotassium intakeSodium polystyrene sulfonateZS-9

Identifiers

PMID27194424
PMCPMC5115995
OpenAlexW2287589907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.